Patient-reported barriers are associated with lower hepatocellular carcinoma surveillance rates in patients with cirrhosis

Hepatology

Volumn 65, Issue 3, 2017, Pages 875-884

  Farvardin, Sherean ^a   Patel, Jaimin ^a   Khambaty, Maleka ^a   Yerokun, Olutola A ^a   Mok, Huram ^a   Tiro, Jasmin A ^b,c   Yopp, Adam C ^a,b   Parikh, Neehar D ^d   Marrero, Jorge A ^a   Singal, Amit G ^a,b,c  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL PAIN; ADULT; ARTICLE; ATTITUDE TO HEALTH; CANCER EPIDEMIOLOGY; CANCER PATIENT; CLINICAL PRACTICE; DISEASE ASSOCIATION; EATING; ELECTRONIC MEDICAL RECORD; FEMALE; HEALTH SURVEY; HEALTHY DIET; HUMAN; HYPERTRANSAMINASEMIA; ICD-9; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PATIENT EDUCATION; PRIORITY JOURNAL; TERTIARY CARE CENTER; ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; EARLY CANCER DIAGNOSIS; EDUCATIONAL STATUS; INSURANCE; LIVER NEOPLASMS; PATIENT COMPLIANCE; RISK ASSESSMENT; SELF REPORT; SOCIOECONOMICS; STANDARDS; STATISTICS AND NUMERICAL DATA; TRENDS; UNITED STATES;

ADULT; ATTITUDE TO HEALTH; CARCINOMA, HEPATOCELLULAR; CONTINENTAL POPULATION GROUPS; EARLY DETECTION OF CANCER; EDUCATIONAL STATUS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INSURANCE COVERAGE; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; POPULATION SURVEILLANCE; RISK ASSESSMENT; SELF REPORT; SOCIOECONOMIC FACTORS; UNITED STATES;

EID: 84994750422     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28770     Document Type: Article

References (31)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–2576.
2. Singal AG, Marrero JA. Recent advances in the treatment of hepatocellular carcinoma. Curr Opin Gastroenterol 2010;26:189–195.
3. Altekruse SF, McGlynn KA, Reichman ME. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005. J Clin Oncol 2009;27:1485–1491.
4. Ha J, Yan M, Aguilar M, Bhuket T, Tana M, Liu B, et al. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the U.S. Cancer 2016;122:2512–2523.
5. Sloane D, Chen H, Howell C. Racial disparity in primary hepatocellular carcinoma: tumor stage at presentation, surgical treatment and survival. J Natl Med Assoc 2006;98:1934–1939.
6. Singal AG, Pillai A, Tiro J. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis. PLoS Med 2014;11:e1001624.
7. Singal AG, Yopp A, Skinner CS, Packer M, Lee WM, Tiro JA. Utilization of hepatocellular carcinoma surveillance among American patients: a systematic review. J Gen Intern Med 2012;27:861–867.
8. Singal AG, Li X, Tiro J, Kandunoori P, Adams-Huet B, Nehra M, Yopp A. Racial, social, and clinical determinants of hepatocellular carcinoma surveillance. Am J Med 2015;128:90.e1-7.
9. Singal AG, Yopp AC, Gupta S, Skinner CS, Halm EA, Okolo E, et al. Failure rates in the hepatocellular carcinoma surveillance process. Cancer Prev Res (Phila) 2012;5:1124–1130.
10. Collier J, Sherman M. Screening for hepatocellular carcinoma. Hepatology 1998;27:273–278.
11. Henrion J, Libon E, De Maeght S, Deltenre P, Schapira M, Ghilain JM, et al. [Screening for hepatocarcinoma in a cohort with cirrhosis mainly of alcoholic origin]. [Article in French]. Gastroenterol Clin Biol 2003;27:534–539.
12. Klein WM, Bloch M, Hesse BW, McDonald PG, Nebeling L, O'Connell ME, et al, Tesauro G. Behavioral research in cancer prevention and control: a look to the future. Am J Prev Med 2014;46:303–311.
13. Rakowski W, Breslau ES. Perspectives on behavioral and social science research on cancer screening. Cancer 2004;101(5 Suppl):1118–1130.
14. Davila JA, Morgan RO, Richardson PA, Du XL, McGlynn KA, El-Serag HB. Use of surveillance for hepatocellular carcinoma among patients with cirrhosis in the United States. Hepatology 2010;52:132–141.
15. Glanz K, Bishop DB. The role of behavioral science theory in development and implementation of public health interventions. Annu Rev Public Health 2010;31:399–418.
16. Nehra MS, Ma Y, Clark C, Amarasingham R, Rockey DC, Singal AG. Use of administrative claims data for identifying patients with cirrhosis. J Clin Gastroenterol 2013;47:e50–e54.
17. Bastani R, Glenn BA, Taylor VM, Chen MS, Jr., Nguyen TT, Stewart SL, Maxwell AE. Integrating theory into community interventions to reduce liver cancer disparities: The Health Behavior Framework. Prev Med 2010;50:63–67.
18. Maxwell AE, Bastani R, Chen MS, Jr., Nguyen TT, Stewart SL, Taylor VM. Constructing a theoretically based set of measures for liver cancer control research studies. Prev Med 2010;50:68–73.
19. Dalton-Fitzgerald E, Tiro J, Kandunoori P, Halm EA, Yopp A, Singal AG. Practice patterns and attitudes of primary care providers and barriers to surveillance of hepatocellular carcinoma in patients with cirrhosis. Clin Gastroenterol Hepatol 2015;13:791–798.e1.
20. Singal A, Volk M, Rakoski M, Fu S, Su G, McCurdy H, Marrero J. Patient involvement is correlated with higher HCC surveillance in patients with cirrhosis. J Clin Gastroenterol 2011;45:727–732.
21. Beatty P, Willis G. Research synthesis: the practice of cognitive interviewing. Public Opin Q 2007;71:287–311.
22. Willis G. Cognitive interviewing: a tool for improving questionnaire design. Thousand Oaks, CA: Sage; 2004.
23. Artinyan A, Mailey B, Sanchez-Luege N, Khalili J, Sun CL, Bhatia S, et al. Race, ethnicity, and socioeconomic status influence the survival of patients with hepatocellular carcinoma in the United States. Cancer 2010;116:1367–1377.
24. Shebl FM, Capo-Ramos DE, Graubard BI, McGlynn KA, Altekruse SF. Socioeconomic status and hepatocellular carcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2012;21:1330–1335.
25. Fox SA, Heritage J, Stockdale SE, Asch SM, Duan N, Reise SP. Cancer screening adherence: does physician-patient communication matter? Patient Educ Couns 2009;75:178–184.
26. Price-Haywood EG, Harden-Barrios J, Cooper LA. Comparative effectiveness of audit-feedback versus additional physician communication training to improve cancer screening for patients with limited health literacy. J Gen Intern Med 2014;29:1113–1121.
27. Green AR, Peters-Lewis A, Percac-Lima S, Betancourt JR, Richter JM, Janairo MP, et al. Barriers to screening colonoscopy for low-income Latino and white patients in an urban community health center. J Gen Intern Med 2008;23:834–840.
28. Sabatino SA, Lawrence B, Elder R, Mercer SL, Wilson KM, DeVinney B, et al. Effectiveness of interventions to increase screening for breast, cervical, and colorectal cancers: nine updated systematic reviews for the guide to community preventive services. Am J Prev Med 2012;43:97–118.
29. Singal AG, Tiro JA, Gupta S. Improving hepatocellular carcinoma screening: applying lessons from colorectal cancer screening. Clin Gastroenterol Hepatol 2013;11:472–477.
30. Singal AG, Gupta S, Tiro JA, Skinner CS, McCallister K, Sanders JM, et al. Outreach invitations for FIT and colonoscopy improve colorectal cancer screening rates: a randomized controlled trial in a safety net health system. Cancer 2016;122:456–463.
31. Singal AG, Chan V, Getachew Y, Guerrero R, Reisch JS, Cuthbert JA. Predictors of liver transplant eligibility for patients with hepatocellular carcinoma in a safety net hospital. Dig Dis Sci 2012;57:580–586.